CapsoVision, Inc. (CV)

Chart not available yet

Data will show when the stock starts trading on Jul 1, 2025.

Market Cap	241.99M
Revenue (ttm)	12.04M
Net Income (ttm)	-21.07M
Shares Out	46.09M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CV

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies that are deployed in our capsule endoscopy solutions to identify abnormalities of the gastrointestinal tract for diagnostic and screening purposes. We developed our first capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 1, 2025
• Employees: 90
• Stock Exchange: NASDAQ
• Ticker Symbol: CV
• Website: https://capsovision.com/

Financial Performance

Financial numbers in USD